Evidence map›Paper›PMID 38800901›Full record

ArticleACS biomaterials science & engineering2024

Reduced Graphene-Oxide-Doped Elastic Biodegradable Polyurethane Fibers for Cardiomyocyte Maturation.

Alan Taylor, Jiazhu Xu, Nicholas Rogozinski, Huikang Fu, Lia Molina Cortez, Sara McMahan, Karla Perez, Yan Chang, Zui Pan, Huaxiao Yang and 2 more

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alan TaylorDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.
Jiazhu XuDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.
Nicholas RogozinskiDepartment of Biomedical Engineering, University of North Texas, Denton, Texas 76207, United States.
Huikang FuDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.
Lia Molina CortezDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.
Sara McMahanDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.
Karla PerezDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.
Yan ChangDepartment of Graduate Nursing, University of Texas at Arlington, Arlington, Texas 76010, United States.
Zui PanDepartment of Graduate Nursing, University of Texas at Arlington, Arlington, Texas 76010, United States.ORCID 0000-0003-4105-901X
Huaxiao YangDepartment of Biomedical Engineering, University of North Texas, Denton, Texas 76207, United States.ORCID 0000-0001-9335-8201
Jun LiaoDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.
Yi HongDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, United States.ORCID 0000-0002-5846-2596

Funding

Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North TexasT32HL134613 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI NGUYEN, KYTAI TRUONG · 2017 to 2021
$1.1M
Bioactive injectable blends for cardiac stem cell recruitmentR15HL140503 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI HONG, YI · 2018 to 2018
$460k
An Inverted Nikon A1R Laser Scanning Confocal MicroscopeS10OD025230 · OD · UNIVERSITY OF TEXAS ARLINGTON · PI PAN, ZUI · 2019 to 2019
$449k
Zinc Protection Against Ischemia-Reperfusion Injury in HeartR15HL168628 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI PAN, ZUI · 2023 to 2023
$443k
NOTCH signaling on the underdeveloped cardiac vascularization of hypoplastic left heart syndrome in the hiPSC-derived vascularized cardiac organoidsR15HD108720 · NICHD · UNIVERSITY OF NORTH TEXAS · PI YANG, HUAXIAO · 2022 to 2022
$438k
A Controlled Septal Ablation for Inoperable Hypertrophic CardiomyopathyR15HL159599 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI LIAO, JUN · 2022 to 2022
$433k
American Heart Association-American Stroke Association 959644NHLBI NIH HHS R15 HL140503NHLBI NIH HHS R15 HL159599NHLBI NIH HHS R15 HL168628NHLBI NIH HHS T32 HL134613NICHD NIH HHS R15 HD108720NIH HHS S10 OD025230
6 · The paper itself

Abstract

Conductive biomaterials offer promising solutions to enhance the maturity of cultured cardiomyocytes. While the conventional culture of cardiomyocytes on nonconductive materials leads to more immature characteristics, conductive microenvironments have the potential to support sarcomere development, gap junction formation, and beating of cardiomyocytes in vitro. In this study, we systematically investigated the behaviors of cardiomyocytes on aligned electrospun fibrous membranes composed of elastic and biodegradable polyurethane (PU) doped with varying concentrations of reduced graphene oxide (rGO). Compared to PU and PU-4%rGO membranes, the PU-10%rGO membrane exhibited the highest conductivity, approaching levels close to those of native heart tissue. The PU-rGO membranes retained anisotropic viscoelastic behavior similar to that of the porcine left ventricle and a superior tensile strength. Neonatal rat cardiomyocytes (NRCMs) and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) on the PU-rGO membranes displayed enhanced maturation with cell alignment and enhanced sarcomere structure and gap junction formation with PU-10%rGO having the most improved sarcomere structure and CX-43 presence. hiPSC-CMs on the PU-rGO membranes exhibited a uniform and synchronous beating pattern compared with that on PU membranes. Overall, PU-10%rGO exhibited the best performance for cardiomyocyte maturation. The conductive PU-rGO membranes provide a promising matrix for in vitro cardiomyocyte culture with promoted cell maturation/functionality and the potential for cardiac disease treatment.

Indexed as

GraphiteInduced Pluripotent Stem CellsMyocytes, CardiacPolyurethanesAnimalsBiocompatible MaterialsCell DifferentiationCells, CulturedElasticityHumansRatsTissue ScaffoldsBiocompatible Materialsgraphene oxideGraphitePolyurethanesbiodegradable polyurethanecardiomyocytesconductivitymaturationreduced graphene oxide

Identifiers

PMID38800901
PMCPMC12208712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.